NCT00648336View on ClinicalTrials.gov

Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

Mercaptopurine 50 mg

50mg, single dose fasting

DRUG

Purinethol® Tablets 50 mg

50mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648336 - Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg | Biotech Hunter | Biotech Hunter